domingo, 30 de marzo de 2025

FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors Medication Can be Given Up to Once Every 2 Months

https://www.fda.gov/news-events/press-announcements/fda-approves-novel-treatment-hemophilia-or-b-or-without-factor-inhibitors?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario